Cytec Beats Estimates; Planning to Sell Building Block Chemicals

Cyctec reported fourth-quarter earnings of $48 million, or 95 cts/share, on sales of $700 million, the company announced today. Results beat analyst consensus estimates of 64 cts/share. Earnings rose strongly from the fourth-quarter of 2009, when they totaled $9.8 million, or 20 cts/share. Sales rose somewhat, from $648 million. Earnings included a one-time $9.7 million, or 19 cts/share, income tax benefit related to the reversal of deferred tax valuation in some of Cytec's international operations. Full-year 2010 earnings were $2.99/share, on total sales of $2.7...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers